Ian McFarland

McFarland joins the company as a tech industry veteran and entrepreneur with a long track record of identifying disruptive trends, which stretches back to his work on worldwide distributed Hypertext systems starting in the late 1980s. Most recently, he served as CEO of Zenio where he oversaw the development of next-generation software planning and process management tools. Prior to that, McFarland served as CTO of Pear Therapeutics, where he led multiple teams in spearheading agile processes of iterative development, and supported a range of regulated products in the company's pipeline. McFarland's teams helped build digital therapeutics for a number of substance-use disorders, as well as the first piece of software ever cleared by the FDA to treat disease.